HOME
FAQs
BLOG
SUBMIT LISTING/OFFER
✕
Filter by
Categories
Tags
Authors
Show all
All
Patents
All
505(b)(2)
alternative path
Business strategy
Clinical Trials
CMS
deadlines
FDA
FDA Approval
financial impact
Grants
history
institutional path
invention
IRS
Marketing
Medicaid
medical patent
Medicare
orphan drugs
Patent
Patent Maestro
Patent Strategy
patents
Process
ROI
Strategy
tax
time
Timing
Transfers
All
Kenneth Pearce
May 18, 2026
Practical Strategic Reasons For Manufacturers Licensing A Medical Patent
May 13, 2026
The Market Before The Market: Two Bites Of The Apple
May 11, 2026
The 5% Market Share Mystery: The Tale of the Surgeon’s Journey
May 6, 2026
Transitioning Pharmaceutical Phase III Data into Market Exclusivity
March 18, 2026
Keeping Your Medical Patent Journey Shipshape
March 16, 2026
Phase III “Death” – Tragedy or Transformation?
March 11, 2026
The Fed and the Funnel: How Interest Rates Affect Your Medical Invention
March 9, 2026
From Kerosene, Coal Tar, Snake Oil & Whiskey: Evolution of Today’s Medical Patent
February 24, 2026
Not Your Grandfather’s Orphan Drug Status
February 23, 2026
Successful Phase I Clinical Trials Can Improve Medical Patent Value
February 17, 2026
The Silent Killer!
February 16, 2026
The 505(b)(2) Advantage: “Hybrid” is the Power Move in 2026
February 11, 2026
The Surgeon and the 510(k): Why Great Inventions Get Stuck
February 10, 2026
The Compliance Illusion: Navigating Class 1 Device Realities
February 3, 2026
Orchestrating Technology To The Patient℠: The MPB Lifecycle Strategy
